Clinical Trials Browser

Phase 2 × Breast Neoplasms, Male × Vorinostat × Clear all

NCT00132002 2015-03-19

Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer

Phase 2 Terminated

14 enrolled 6 charts

Breast Neoplasms, Breast Neoplasms, Male